Pembrolizumab with Carboplatin and Paclitaxel Versus Alternative Systemic Treatments Recommended for the First-Line Treatment of Recurrent/Metastatic Head and Neck Cancer: An Indirect Treatment Comparison. - Dzienis M; Mojebi A; Keeping S; Black CM; Giezek H; Naicker N; Vanetta C; Park JE; Chan K; Merchant S; Zheng D (Advances in therapy, 2025)